Professor, Surgery (Neurosurgery), Case Western Reserve University School of Medicine
Neurosurgery
Dr. Michael A. Vogelbaum, MD
|
|
Give Review
Michael Vogelbaum practices Neurosurgery. He went to University of Virginia School of Medicine. He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)" and "Fellow (FAANS)". Michael A. Vogelbaum is also a published doctor. He has 77 publication published. The most recent publication is: Radiosurgery for Pediatric Brain Tumors. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- The intersection of cancer, cancer stem cells, and the immune System: therapeutic opportunities.
- Radiosurgery for Pediatric Brain Tumors.
- Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.
- Myeloid derived suppressor cell infiltration of murine and human Gliomas is associated with reduction of tumor infiltrating lymphocytes.
- Tumor Progression in Patients Receiving Adjuvant Whole-Brain Radiotherapy vs Localized Radiotherapy After Surgical Resection of Brain Metastases.
- Convection-enhanced delivery for the treatment of glioblastoma.
- Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
- Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
- Use of high-field intraoperative magnetic resonance imaging to enhance the extent of resection of enhancing and nonenhancing Gliomas.
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
- A randomized trial of bevacizumab for newly diagnosed glioblastoma.
- Using Higher Isodose Lines for Gamma Knife Treatment of 1 to 3 Brain Metastases is Safe and Effective.
- Challenges relating to solid tumour Brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.
- Challenges relating to solid tumour Brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.
- Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
- Is There a Shortage of Neurosurgeons in the United States?
- A nomogram for individualized estimation of survival among patients with Brain metastasis.
- Treatment of Five or More Brain Metastases with Stereotactic Radiosurgery.
- The Importance of the Conformality, Heterogeneity, and Gradient Indices in Evaluating Gamma Knife Radiosurgery Treatment Plans for Intracranial Meningiomas.
- Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial.
- Relationship Between HER2 Status and Prognosis in Women with Brain Metastases from Breast Cancer.
- Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of Brain metastases in women with breast cancer.
- Stereotactic radiosurgical treatment of Brain metastases to the choroid plexus.
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.
- Silencing IL-13R{alpha}2 promotes glioblastoma cell death via endogenous signaling.
- Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas.
- Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
- Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade Gliomas.
- Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases.
- Gamma knife stereotactic radiosurgery for the management of incidentally-identified Brain metastasis from non-small cell lung cancer.
- Clinical trial end points for high-grade glioma: the evolving landscape.
- Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular Schwannomas.
- Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.
- IL-8 is a mediator of NF-κB induced invasion by Gliomas.
- Thin layer chromatography-based assay of O6-methylguanine-DNA methyltransferase activity in tissue.
- Stereotactic radiosurgery for single Brainstem metastases: the cleveland clinic experience.
- Intracranial Meningiomas of atypical (WHO grade II) histology.
- Opportunities for clinical research in meningioma.
- p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
- Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.
- Updated response assessment criteria for high-grade Gliomas: response assessment in neuro-oncology working group.
- Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin.
- Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma Brain metastases.
- PTPmu suppresses glioma cell migration and dispersal.
- Gender, race, and survival: a study in non-small-cell lung cancer Brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analy...
- Novel drug delivery strategies in neuro-oncology.
- End point assessment in Gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.
- Long-term experience with World Health Organization grade III (malignant) Meningiomas at a single institution.
- Modern treatment of Cerebral metastases: Integrated Medical Learning(SM) at CNS 2007.
- Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendroGliomas and mixed anaplastic oligoastrocytomas: RTO...
- The future of clinical research beyond phase III trials.
- Salvage stereotactic radiosurgery effectively treats recurrences from whole-Brain radiation therapy.
- CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT...
- Stereotactic radiosurgical treatment of Brain metastases in older patients.
- Multidisciplinary management of colorectal Brain metastases: a retrospective study.
- Stereotactic radiosurgical treatment of parenchymal Brain metastases from prostate adenocarcinoma.
- Quantum dots are phagocytized by macrophages and colocalize with experimental Gliomas.
- Five-year survivors of Brain metastases: a single-institution report of 32 patients.
- RPA classification has prognostic significance for surgically resected single Brain metastasis.
- Local control of Brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin.
- The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making.
- Resectable Brain metastases.
- Use of the Radiation Therapy Oncology Group recursive partitioning analysis classification system and predictors of survival in 19 women with Brain metastases from ova...
- Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
- Mapping prosody: correlation of functional magnetic resonance imaging with intraoperative electrocorticography recordings in a patient with a right-sided temporooccipi...
- S100beta as a predictor of Brain metastases: Brain versus cerebrovascular damage.
- Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
- In touch with robotics: neurosurgery for the future.
- Epidermal growth factor receptor antagonists: novel therapy for the treatment of high-grade Gliomas.
- Cyclooxygenase-2 in oligodendroglial neoplasms.
- Serum S100beta: a noninvasive marker of blood-Brain barrier function and Brain lesions.
- Intracranial navigation by using low-field intraoperative magnetic resonance imaging: preliminary experience.
- Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme.
- Caspase-9 transduction overrides the resistance mechanism against p53-mediated apoptosis in U87MG glioma cells.
- IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
- Convection-enhanced drug delivery for Gliomas.
Schools
University Of Virginia School Of Medicine
Barnes Hospital
Procedures Preformed
- Cerebrospinal Fluid (CSF) Shunt - Insertion, Repair or Removal
- Craniectomy, Craniotomy, Surgery of Skull Base, Neuroendoscopy
- Dural Repair or Other Spinal Spinal Cord Repair
- Lamina Procedures (incl. Laminectomy, Laminoplasty, Laminotomy)
- View All
Conditions Treated
- Acoustic Neuroma
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Brain Cancer
- View All
Doctors Specialties
- Neurosurgery
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Fellow (FAANS)
Education
-
Washington University -
Washington University - Barnes-Jewish Hospital -
University of Virginia School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1598732380 | |
| NPPES Provider LastName | VOGELBAUM | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Neurosurgery | |
| Total Claim Count | 37.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598732380 |
| Last Name Of The Provider | VOGELBAUM |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
Dr. Jonathan Z. Baskin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gasser H. Al-Shyal, MD |
|
|
Dr. Elizabeth E. Abbott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzanne Tharin, MD |